Results 11 to 20 of about 24,877 (234)

Relation between ocular paraneoplastic syndromes and Immune Checkpoint Inhibitors (ICI): review of literature [PDF]

open access: yesJournal of Ophthalmic Inflammation and Infection, 2023
Purpose To describe different ocular paraneoplastic syndromes in patients treated with Immune Checkpoint Inhibitors (ICI), its relation with different types of ICI and different types of tumors, and its implications for treatment. Methods A comprehensive
Pauline Casselman   +2 more
doaj   +2 more sources

Psychiatric manifestations of paraneoplastic syndromes [PDF]

open access: yesEuropean Psychiatry, 2022
Introduction Paraneoplastic syndromes (PS) result from indirect effects of neoplasms. In 50% of the cases the symptoms precede the diagnosis and run independently.
M. Lemos, A. Lourenço, M. Ribeiro
doaj   +2 more sources

Clinical Features of Cutaneous Paraneoplastic Syndromes in Hodgkin Lymphoma [PDF]

open access: yesJournal of Investigative Medicine High Impact Case Reports
Cutaneous paraneoplastic syndromes due to Hodgkin lymphoma present with a wide spectrum of clinical manifestations from generalized pruritus to exfoliative erythroderma. We summarize the clinical findings and outcomes of 14 patients with Hodgkin lymphoma
Benjamin J. McCormick MD, MS   +3 more
doaj   +2 more sources

Paraneoplastic neurological syndromes

open access: yesClinical and Experimental Immunology, 2014
Summary Paraneoplastic neurological syndromes are immune-mediated erroneous attacks on the central or peripheral nervous systems, or both, directed originally against the tumour itself. They have been known for more than 40 years, but recently the discovery of new subgroups of paraneoplastic encephalitis syndromes with a remarkably good ...
F, Leypoldt, K-P, Wandinger
openaire   +5 more sources

The Broad Spectrum of Gallbladder Paraneoplastic Syndromes [PDF]

open access: yesGastro Hep Advances
Gallbladder carcinoma (GBC) is a rare gastrointestinal tumor with a reported incidence of 1 in 100,000 in the United States. GBC may present with subtle signs and symptoms that can be missed on routine examination and/or confused with other conditions ...
Shuhaib Ali   +4 more
doaj   +2 more sources

The Paraneoplastic Syndromes [PDF]

open access: yesCA: A Cancer Journal for Clinicians, 1968
T C, Hall, L, Nathanson
openaire   +4 more sources

Patient‐Reported Outcomes with Selpercatinib Treatment Among Patients with RET‐Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO‐001 Trial

open access: yesThe Oncologist, EarlyView., 2021
Abstract Background Medullary thyroid cancer (MTC) standard of care includes multikinase inhibitors (MKIs), which can exacerbate disease‐related diarrhea, primarily because of non‐RET kinase inhibition. We report diarrhea and other patient‐reported outcomes (PROs) with selpercatinib, a highly selective RET inhibitor, among patients with RET‐mutant MTC ...
Lori J. Wirth   +10 more
wiley   +1 more source

Paraneoplastic cerebellar degeneration associated with lymphoepithelial carcinoma of the tonsil [PDF]

open access: yes, 2013
Background: Paraneoplastic cerebellar degeneration (PCD) is a classical tumor-associated, immune-mediated disease typically associated with gynecological malignancies, small-cell lung-cancer or lymphoma.
Hartmann, Sylvia   +5 more
core   +1 more source

Immune myopathies with perimysial pathology: Clinical and laboratory features [PDF]

open access: yes, 2018
ObjectiveImmune myopathies with perimysial pathology (IMPP) have a combination of damage to perimysial connective tissue and muscle fiber necrosis, more prominent near the perimysium.
Bucelli, Robert C, Pestronk, Alan
core   +2 more sources

Diagnosis and treatment of paraneoplastic neurological disorders [PDF]

open access: yes, 2004
In about two thirds of cases, patients with paraneoplastic neurological disorders present to the neurologist without a known tumor. Due to the ongoing immune response, this tumor tends to stay biologically relatively benign, and therefore difficult to ...
Graus, F., Voltz, R.
core   +1 more source

Home - About - Disclaimer - Privacy